Rheumatoid lung disease

RHEUMAT_LUNG

adult-onset Still's disease: adult-onset Still disease (AOSD) is a rare inflammatory multisystem disorder characterized clinically by fever of unknown origin, arthralgia or arthritis, hyperleucocytosis, and typical skin rash.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

135

4. Check minimum number of events

None

135

5. Include endpoints

None

135

6. Filter based on genotype QC (FinnGen only)

135

Control definitions (FinnGen only)

Control exclude
ILD_SYST_AUTO_DISEASES

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 998 519 473
Only index persons 705 370 335
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 70.83 71.81 69.83
Only index persons 70.05 70.59 69.45

-FinnGen-

Key figures

All Female Male
Number of individuals 135 59 76
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 71.11 70.62 71.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
114
Matched controls
1139
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
206.8
98.1
97
30
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
+∞
88.4
73
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
105.1
83.4
100
72
A07EC01
ATC
sulfasalazine; oral, rectal
57.3
60.9
73
34
P01BA02
ATC
hydroxychloroquine; oral
41.6
58.1
78
56
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
37.9
51.7
69
44
J99.0
ICD-10 Finland
Rheumatoid lung disease
+∞
44.8
40
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
75.2
39.1
43
9
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
58.5
38.2
44
12
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
43.3
38.1
47
18
H02AB06
ATC
prednisolone; systemic
33.2
37.3
108
400
L04AA13
ATC
leflunomide; oral
56.3
37.1
43
12
M05.1
ICD-10 Finland
Rheumatoid lung disease
+∞
35.2
32
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
129.7
35.1
36
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
59.8
27.2
31
7
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
17.6
26.8
44
39
L04AX01
ATC
azathioprine; systemic
38.0
26.3
33
12
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
21.3
24.7
37
25
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
17.0
24.2
40
35
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.4
21.8
81
283
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
53.9
19.0
22
5
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
50.8
18.0
21
5
L88
ICPC
Rheumatoid/seropositive arthritis
20.6
17.6
26
16
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.5
16.1
67
236
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
29.9
15.3
20
8
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.6
15.0
38
70
L04AA06
ATC
mycophenolic acid; systemic
92.3
15.0
16
*
M01CB01
ATC
sodium aurothiomalate; parenteral
26.6
14.8
20
9
TGC00
NOMESCO Finland
Bronchial lavation
17.8
14.3
22
15
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
18.4
13.2
20
13
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
52.7
12.2
14
*
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
39.5
11.6
14
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.6
11.3
23
29
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
48.5
11.2
13
*
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
24.4
11.0
15
7
M01CB03
ATC
auranofin; oral
66.4
10.8
12
*
L04AA01
ATC
[U] ciclosporin; systemic
66.4
10.8
12
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
12.4
10.8
19
18
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
44.2
10.2
12
*
M05BA04
ATC
alendronic acid; oral
6.2
10.0
28
57
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
24.2
9.6
13
6
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
20.7
9.2
13
7
H02AB07
ATC
prednisone; oral
4.7
9.0
33
91
L04AB01
ATC
etanercept; parenteral
54.3
8.8
10
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
6.4
8.7
23
43
ZX120
NOMESCO Finland
Intravenous
6.1
8.7
24
48
L04AB04
ATC
adalimumab; parenteral
96.9
8.5
9
*
NDL52
NOMESCO Finland
Tenosynovectomy of hand
96.9
8.5
9
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.3
8.5
34
102
R06.0
ICD-10 Finland
Dyspnoea
3.5
8.4
49
200
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.0
8.3
37
123
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
36.2
8.2
10
*
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
24.1
8.2
11
5
R50.9
ICD-10 Finland
Fever, unspecified
4.5
8.0
30
84
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
85.4
7.5
8
*
L04AD01
ATC
ciclosporin; systemic
85.4
7.5
8
*
NDG30
NOMESCO Finland
Fusion of wrist, total
85.4
7.5
8
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
17.2
7.4
11
7
GX1K5
NOMESCO Finland
Diffusion capacity
+∞
7.4
7
*
M01AC06
ATC
meloxicam; systemic, rectal
3.1
7.2
55
266
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
7.2
72
418
XG410
NOMESCO Finland
Flow-volume spirometry
6.7
6.9
17
29
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.3
6.9
16
25
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.4
6.8
20
43
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.5
6.6
19
40
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
19.3
6.4
9
5
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
19.3
6.4
9
5
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
4.9
6.3
20
47
J990, M058
ICD-10 Finland
NA
+∞
6.3
6
*
L40.5
ICD-10 Finland
Arthropathic psoriasis
+∞
6.3
6
*
WZC30
NOMESCO Finland
Teaching
3.9
6.3
26
80
GD1AD
NOMESCO Finland
Thorax CT examination
7.4
6.3
14
21
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.7
6.1
64
366
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
7.1
6.1
14
22

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005719) IgG [Mass/volume] in Serum or Plasma
53
65
12.78
43.45
5.2
2.2
g/l
9.1
10.5
1.24
53
58
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
36
25
19.27
41.54
1.7
1.4
iu/ml
0.2
0.1
—
12
5
(3037522) Nuclear Ab [Titer] in Serum
54
111
7.44
27.70
1.6
1.3
titre
702.0
515.4
0.25
20
26
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
51
8.24
21.59
3.4
3.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
67
216
5.17
20.14
12.6
5.2
—
—
—
0
0
(3020891) Body temperature
30
45
8.29
20.06
9.3
4.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
42
91
6.25
19.84
6.0
4.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
23
11.23
19.31
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
10
18.02
18.81
1.5
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
37
75
6.42
18.63
1.2
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
53
152
5.09
18.10
1.5
1.2
u/ml
107.5
25.4
2.61
24
50
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
37
81
5.91
17.11
1.2
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
53
166
4.61
15.97
1.4
1.2
iu/ml
129.5
39.6
1.29
35
61
(3017181) Myelocytes/100 leukocytes in Blood
39
97
5.25
15.55
6.5
3.6
%
1.1
1.0
0.10
20
38
(40761535) Cells panel - Urine sediment
37
90
5.29
15.10
8.9
3.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
26
8.86
14.84
1.5
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
36
7.50
14.62
2.4
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
36
89
5.15
14.37
6.4
3.7
%
0.2
0.2
0.10
18
34
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
22
9.29
13.97
1.5
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
22
9.29
13.97
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
25
8.68
13.93
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
17
10.54
13.71
2.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
17
10.54
13.71
2.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
17
10.54
13.71
2.6
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
28
58
5.83
13.55
2.6
1.8
ug/l
2.7
5.6
0.25
28
52
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
36
7.11
13.40
3.2
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
27
8.03
13.06
1.4
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
21
9.12
13.05
1.6
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
32
81
4.87
12.31
6.2
3.6
%
0.3
0.5
0.28
12
24
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
16
9.65
11.32
3.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
36
107
4.22
11.24
1.2
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
27
7.06
10.55
3.5
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
189
3.50
10.42
3.3
1.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
72
354
3.22
10.21
6.4
4.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
22
47
5.40
10.18
8.4
3.8
mmol/l
4.0
3.9
0.58
22
41
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
132
3.75
10.07
2.1
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
30
84
4.31
10.06
7.3
3.9
%
0.0
0.3
0.49
15
30
(44806118)
13
16
8.88
9.91
1.5
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
16
8.88
9.91
3.8
1.4
—
—
—
0
0
(44790047)
13
16
8.88
9.91
1.5
1.6
—
—
—
0
0
(44790049)
13
16
8.88
9.91
1.5
1.6
—
—
—
0
0
(44790048)
13
16
8.88
9.91
1.5
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
39
134
3.69
9.83
2.3
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
23
53
5.03
9.77
1.1
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
77
4.33
9.59
5.9
3.7
ml/min/173m2
54.2
58.4
0.32
13
28
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
15
23
7.21
9.57
1.3
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
15
8.68
9.00
1.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
19
7.46
8.60
3.8
4.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
30
5.92
8.43
1.4
1.2
g/l
1.2
1.2
0.01
16
30
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
15
28
5.90
7.92
1.4
1.2
g/l
0.2
0.3
2.08
15
28
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
21
6.74
7.87
1.9
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
75
420
2.77
7.79
2.9
2.3
nmol/l
84.7
77.0
1.30
70
362
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
93
582
2.92
7.78
7.1
7.2
mmol/l
1.2
1.2
0.09
81
489
(3042936) Bacteria identified in Isolate by Culture
42
173
3.07
7.75
2.7
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
60
302
2.78
7.64
10.0
3.8
estimate
0.0
0.0
0.00
18
93
(42870588) Differential panel, method unspecified - Blood
64
336
2.72
7.47
14.6
5.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
21
56
4.26
7.41
4.3
2.8
%
1.5
1.0
2.32
21
56
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
81
483
2.69
7.26
5.1
4.0
ng/l
56.3
36.6
0.49
72
362
(3014576) Chloride [Moles/volume] in Serum or Plasma
38
155
3.02
7.07
7.8
6.9
mmol/l
102.4
104.2
1.20
38
150
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
73
418
2.63
7.05
6.5
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
85
526
2.66
6.96
8.8
3.8
estimate
0.0
0.0
0.00
18
100
(3009261) Glucose [Presence] in Urine by Test strip
86
537
2.66
6.89
8.7
3.8
estimate
0.0
0.0
0.00
19
94
(3000494) Fungus identified in Specimen by Culture
33
130
3.04
6.48
2.0
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
49
239
2.65
6.46
10.0
3.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
84
531
2.54
6.37
10.1
5.2
estimate
0.0
0.0
0.00
19
100
(3020630) Protein [Mass/volume] in Serum or Plasma
30
113
3.13
6.35
1.7
2.4
g/l
64.4
65.1
0.18
25
99
(3000850) Epithelial cells [#/volume] in Urine
49
243
2.60
6.21
4.3
2.7
e6/l
3.8
4.6
0.35
49
216
(4034850)
16
40
4.40
6.09
16.4
13.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
26
94
3.19
5.87
1.4
2.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
23
77
3.40
5.86
5.4
4.0
mmol/l
3.1
2.3
0.57
15
56
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
17
6.27
5.71
4.1
2.8
%
58.8
60.5
—
10
17
(3021788) Differential panel - Synovial fluid
10
17
6.27
5.71
1.3
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
17
6.27
5.71
3.7
2.8
e9/l
4.6
4.6
—
10
17
(3014111) Lactate [Moles/volume] in Serum or Plasma
26
101
2.95
5.18
4.4
6.5
mmol/l
1.6
1.4
0.62
26
92
(3004119) Hemoglobin [Mass/volume] in Venous blood
21
72
3.27
5.14
4.5
3.9
g/l
133.4
127.1
0.63
21
72
(3037467) Urinalysis macro (dipstick) panel - Urine
100
724
2.47
5.10
10.2
4.6
—
—
—
0
0
(4062490)
8
7
12.04
4.85
1.4
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
67
417
2.20
4.83
9.7
4.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
38
190
2.39
4.57
3.5
2.8
e6/l
1.0
1.0
0.01
28
107
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
35
4.00
4.48
1.5
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
53
308
2.19
4.46
4.5
3.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
12
7.94
4.43
1.6
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
6
12.20
4.32
1.1
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
41
3.69
4.31
3.4
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
58
354
2.12
4.27
3.8
4.4
ph
7.4
7.4
0.03
13
68
(3030467) Casts [#/volume] in Urine by Automated count
54
321
2.14
4.26
4.8
3.1
e6/l
0.5
0.5
0.00
45
242
(3024561) Albumin [Mass/volume] in Serum or Plasma
75
505
2.09
4.25
4.6
4.4
g/l
32.4
34.7
2.47
70
471
(3021901) Oxygen saturation in Capillary blood
10
24
4.42
3.96
4.4
3.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
11
7.65
3.92
1.5
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
13
6.46
3.55
1.3
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
30
150
2.29
3.55
5.9
3.3
%
1.9
1.8
0.22
25
134
(3045716) Anion gap in Serum or Plasma
6
6
10.38
3.53
3.2
3.3
mmol/l
6.6
7.8
—
6
6
(40757494) Bilirubin.total [Moles/volume] in Blood
6
6
10.38
3.53
3.8
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
37
3.46
3.43
1.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
60
2.89
3.36
7.3
4.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
19
4.99
3.30
2.8
3.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
14
50
3.01
3.19
1.7
1.2
u/ml
208.4
136.2
0.28
14
41
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
71
2.60
2.94
1.9
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
43
265
1.91
2.90
11.5
7.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.91
2.90
4.3
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.91
2.90
4.3
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.91
2.90
4.3
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.91
2.90
4.3
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
40
241
1.94
2.89
2.8
1.7
mg/l
2.7
1.6
0.46
32
193
(3018095) Leukocytes [#/volume] in Urine
60
414
1.81
2.83
5.7
3.9
e6/l
28.7
76.7
1.15
53
308
(3024263) Appearance of Synovial fluid
5
6
8.59
2.77
1.6
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
23
114
2.23
2.76
4.1
2.4
ug/l
3.5
5.3
1.21
23
97
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
38
3.06
2.65
1.8
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
20
4.18
2.61
7.9
4.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
11
5.65
2.57
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
7
7.36
2.57
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
34
3.10
2.47
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
17
325
0.45
2.45
3.2
3.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
19
92
2.24
2.41
5.0
8.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
13
4.77
2.29
1.0
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
52
364
1.70
2.23
5.2
3.3
e6/l
21.5
226.6
0.63
45
286
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
67
503
1.66
2.19
7.2
4.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
67
503
1.66
2.19
7.0
9.6
inr
1.2
1.3
0.74
19
150
(40760888) Immunoglobulin light chains.free panel - Serum
9
30
3.14
2.19
1.2
6.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
14
4.43
2.17
2.0
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
54
384
1.68
2.17
2.6
3.3
mmol/l
2.3
2.3
0.12
48
332
(3012544) pH of Venous blood
22
120
2.00
2.08
2.5
4.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
26
3.20
2.05
5.3
3.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
39
2.69
1.97
1.4
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
50
357
1.64
1.94
4.9
3.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
139
1.88
1.91
12.7
8.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
22
3.30
1.90
4.7
2.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
22
3.30
1.90
1.3
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
12
4.28
1.84
1.0
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
37
250
1.66
1.76
1.8
1.8
nmol/l
1646.9
1163.8
0.87
32
182
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
13
3.95
1.73
2.6
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
31
2.68
1.69
2.6
4.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
14
3.67
1.63
1.4
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
14
3.67
1.63
4.8
3.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
20
3.09
1.60
1.5
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
15
3.42
1.53
2.4
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
21
2.94
1.52
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
63
498
1.50
1.49
3.1
2.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
5
16
3.20
1.45
1.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
46
2.27
1.44
5.4
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
83
1.91
1.38
1.9
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
38
0.00
1.36
0.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
75
873
0.68
1.35
30.0
18.3
%
39.3
38.0
0.92
35
560
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
62
2.03
1.32
3.3
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
24
2.57
1.32
1.3
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
21
132
1.70
1.30
3.0
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
19
2.69
1.22
1.0
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
38
2.17
1.20
1.6
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
38
2.17
1.20
1.6
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
38
2.17
1.20
1.6
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
26
2.37
1.20
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
33
0.00
1.18
0.0
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
120
1.68
1.16
4.5
3.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
45
2.07
1.07
3.4
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
22
2.32
1.04
1.4
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
22
2.32
1.04
1.4
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
30
0.00
0.98
0.0
2.2
—
2.5
—
0
21
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
16
102
1.65
0.95
3.1
4.1
mmol/l
1.2
1.2
0.00
16
89
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
5
102
0.47
0.94
1.6
2.6
u/l
41.4
30.4
—
5
83
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
58
1.78
0.82
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
34
1.80
0.77
1.2
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
33
259
1.36
0.75
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
68
1.67
0.74
4.3
5.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
55
469
1.29
0.71
2.1
2.1
pmol/l
87.2
95.4
0.85
34
230
(3020961) Endomysium IgA Ab [Titer] in Serum
7
41
1.75
0.71
1.1
1.0
—
—
—
0
0
(3019225) pH of Specimen
15
103
1.51
0.68
5.3
4.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
26
200
1.37
0.67
1.3
1.2
u/ml
0.6
0.9
—
8
53
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
34
275
1.32
0.64
1.4
1.9
pmol/l
624.1
438.3
1.49
29
231
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
20
0.00
0.61
0.0
1.5
—
14.7
—
0
20
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
52
1.57
0.60
1.6
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
31
250
1.31
0.60
4.3
2.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
19
142
1.39
0.58
1.2
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
114
1082
1.34
0.56
40.9
19.8
umol/l
79.8
83.3
0.74
114
1082
(3004789) Transferrin [Mass/volume] in Serum or Plasma
23
183
1.31
0.49
1.9
2.5
g/l
2.2
2.3
0.18
23
165
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
105
1.37
0.43
1.1
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
58
1.40
0.42
1.8
2.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
111
1062
1.25
0.41
28.4
16.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
3.4
—
3.9
—
0
17
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
66
1.39
0.39
2.1
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
66
1.39
0.39
1.4
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
29
246
1.23
0.38
3.2
3.2
mosm/kgh2o
524.8
543.2
0.19
29
209
(3013512) EKG study
42
373
1.18
0.35
4.6
4.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
38
428
0.84
0.34
2.4
2.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
45
1.35
0.34
1.3
1.2
—
—
—
0
0
(4010399)
11
83
1.35
0.33
1.3
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
98
934
1.18
0.33
5.0
4.7
mu/l
1.9
2.0
0.49
92
813
(3044640) Blood type and Crossmatch panel - Blood
39
347
1.17
0.32
4.6
2.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
115
1116
1.21
0.27
54.4
24.3
fl
93.7
91.5
3.61
115
1096
(3000963) Hemoglobin [Mass/volume] in Blood
115
1117
1.20
0.26
55.0
24.5
g/l
128.7
133.5
3.13
115
1094
(3035941) MCH [Entitic mass]
115
1117
1.20
0.26
54.2
24.3
pg
30.6
30.4
0.47
115
1097
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
39
1.29
0.23
1.0
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
41
1.23
0.22
1.0
1.9
—
—
—
0
0
(4035726)
8
101
0.78
0.22
1.4
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(4281824)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
1.1
—
0
5
(3027944) Amphetamines [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
271.4
—
0
8
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
39.0
—
0
8
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
534.6
—
0
8
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
33
362
0.88
0.21
4.4
4.6
%
21.4
22.0
0.08
22
185
(3049717) Cytology report of Urine Cyto stain
6
48
1.26
0.20
1.7
2.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
62
1.14
0.17
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
81
1.12
0.15
3.9
2.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
97
993
0.92
0.13
4.6
4.7
mmol/l
1.4
1.5
0.17
91
892
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
96
980
0.93
0.10
25.7
16.1
ml/min/173m2
74.2
73.7
0.08
86
811
(3041096) Erythrocytes [Presence] in Urine by Automated
32
302
1.08
0.09
7.5
3.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
48
1.04
0.09
1.6
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
98
997
0.94
0.08
4.6
4.8
mmol/l
4.4
4.5
0.53
91
907
(3002256) Pathology report gross observation
15
137
1.11
0.08
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
10
112
0.88
0.07
1.3
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
9
83
1.09
0.07
4.4
3.3
e6/l
0.2
0.3
—
9
83
(3020682) Albumin/Creatinine [Ratio] in Urine
36
375
0.95
0.06
3.1
4.1
mg/mmol
3.3
6.5
1.07
29
241
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
94
955
0.95
0.06
4.3
4.3
mmol/l
1.4
1.3
1.60
89
852
(40761536) Microorganisms panel - Urine sediment
10
90
1.12
0.05
9.7
4.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
20
191
1.06
0.03
4.3
3.1
e6/l
10.0
3.0
0.42
11
112
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
101
1001
1.04
0.02
4.8
5.1
mmol/l
6.1
6.1
0.03
91
894
(3044889) 12 lead EKG panel
76
754
1.02
0.00
5.4
4.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
103
1025
1.02
0.00
5.1
5.4
mmol/l
2.5
2.6
0.54
98
922
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.4
—
113.5
—
0
8
(3011288) Drugs identified in Urine by Screen method
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
6
0.00
0.00
0.0
1.0
—
57.0
—
0
6
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.4
—
75.3
—
0
7
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
0.8
—
0
6
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
64
0.93
0.00
3.5
8.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
83.5
—
0
5
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
117.2
—
0
5
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
7.7
—
0
9
(4027681)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3000492) Spirometry study
8
79
1.01
0.00
2.0
1.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint RHEUMAT_LUNG and mortality.

Females

Parameter HR [95% CI] p-value
RHEUMAT_LUNG 4.335 [3.39, 5.55] < 0.001
Birth year 0.994 [0.99, 1.0] 0.19

During the follow-up period (1.1.1998 — 31.12.2019), 221 out of 379 females with RHEUMAT_LUNG died.

Males

Parameter HR [95% CI] p-value
RHEUMAT_LUNG 3.125 [2.41, 4.05] < 0.001
Birth year 0.988 [0.98, 1.0] 0.015

During the follow-up period (1.1.1998 — 31.12.2019), 209 out of 351 males with RHEUMAT_LUNG died.

Mortality risk

Mortality risk for people of age

years, who have RHEUMAT_LUNG.

N-year risk Females Males
1 0.334% 0.578%
5 2.191% 3.843%
10 5.284% 9.686%
15 10.592% 17.551%
20 19.317% 28.326%

Relationships between endpoints

Index endpoint: RHEUMAT_LUNG – Rheumatoid lung disease

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data